Serial Number
79272459
Owner
QuiaPEG Pharmaceuticals ABAttorney
Cynthia Johnson WaldenFiling Date
Sep 2, 2019
QUIAPEG PHARMACEUTICALS Trademark
Serial Number: 79272459 • Registration: 6854416
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
Virdings Allé 32 B
Uppsala SE-754 50 , SE
Entity Type: 03
Legal Representation
Correspondence Address
Cynthia Johnson Walden Fish & Richardson P.C.
P.O. Box 1022
Minneapolis, MN 55440-1022
UNITED STATES
Trademark Details
Filing Date
September 2, 2019
Registration Date
September 27, 2022
Published for Opposition
July 12, 2022
Goods & Services
Pharmaceuticals, medical and veterinary preparations for the treatment of cancer, cardiovascular disease, respiratory disorders, metabolic disorders, autoimmune disease, neurologic and psychiatric disorders and infectious disease derived from PEGylation technologies; pharmaceutical preparations, namely, a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; pharmaceutical, medical and veterinary substances
Regents for use in industry and science, namely, reagents for use with a drug delivery system comprising phosphotriester linkers for the controlled release of a wide variety of therapeutic agents; cross linking agents being industrial chemicals for use in industry and science; polyethylene glycols for use in industry and science; chemical structures being industrial chemicals, namely, phosphotriester linkers
Scientific and technological services, namely, scientific research, analysis, testing and development in the field of pharmaceuticals, of pharmaceutical, medical and veterinary preparations and substances derived from PEGylation technologies; PEGylation pharmaceuticals research services
